Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Renvela" (77)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
(Codice) 72 products
WHO-DDD
L
IP
Azacitidin Stada 150 mg
304.64
347.75
10 %
Powder for injection suspension: Azacitidinum 150 mg
Spirig HealthCare AG
A / SL / SG
FB
G
IP
V/S
Infanrix DTPa-IPV
PR
PR
k.A.
8 Active Agents
GlaxoSmithKline AG
B
FB
G
IP
CI
Sonotryl
10
PR
PR
k.A.
Coated tablets: Ibuprofenum 200 mg
VERFORA SA
D
FB
G
IP
CI
Sonotryl
20
PR
PR
k.A.
Coated tablets: Ibuprofenum 200 mg
VERFORA SA
D
FB
G
IP
Xenpozyme 4 mg
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 4 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Xenpozyme 4 mg
10
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 4 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Xenpozyme 20 mg
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 20 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Xenpozyme 20 mg
10
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 20 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
L
IP
CI
A
Subutex 2 mg
28 Tablet(s)
25.23
43.55
10 %
Sublingual tablets: Buprenorphinum 2 mg
Indivior Schweiz AG
A+ / SL / SO
FB
G
IP
CI
Dilzem 90 mg retard
20 Tablet(s)
3.26
12.80
10 %
Delayed release tablets: Diltiazemi Hydrochloridum 90 mg
Pfizer AG
B / SL / SO
FB
G
IP
CI
Dilzem 90 mg retard
100 Tablet(s)
14.05
31.70
10 %
Delayed release tablets: Diltiazemi Hydrochloridum 90 mg
Pfizer AG
B / SL / SO
FB
G
L
IP
CI
Januvia 100 mg
-
T
28 Tablet(s)
26.82
44.80
20 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Januvia 100 mg
-
T
98 Tablet(s)
93.85
115.75
20 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Januvia 25 mg
-
T
28 Tablet(s)
26.82
44.80
20 %
Coated tablets: Sitagliptinum 25 mg
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Januvia 25 mg
-
T
98 Tablet(s)
93.85
115.75
20 %
Coated tablets: Sitagliptinum 25 mg
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
SIP
IP
CI
Xarelto 15 mg
14 Tablet(s)
32.17
50.00
10 %
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B / SL / SO
FB
G
SIP
IP
CI
Xarelto 15 mg
28 Tablet(s)
62.83
82.05
10 %
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B / SL / SO
FB
G
SIP
IP
CI
Xarelto 15 mg
98 Tablet(s)
230.43
257.10
10 %
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B / SL / SO
FB
G
IP
Fentalis 25 μg/h
5
15.79
33.60
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Fentalis 50 μg/h
5
31.27
50.40
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Fentalis 100 μg/h
5
58.80
80.35
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Fentalis 25 μg/h
10
27.66
46.50
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Fentalis 50 μg/h
10
56.76
78.15
10 %
Sandoz
Pharmaceuticals AG
● 
A+ / SL / SG
FB
G
IP
Fentalis 100 μg/h
10
103.47
128.95
10 %
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
L
IP
Ceftriaxon Labatec 2 g
i.v.
2 g
9.90
27.20
10 %
Dry substance: Ceftriaxonum 2000 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Ceftriaxon Labatec 2 g
i.v.
10 x 2 g
84.15
107.95
10 %
Dry substance: Ceftriaxonum 2000 mg
Labatec Pharma SA
A / SL / SG
FB
G
IP
CI
CM
Mephadolor 500 Neo
‐
I
-
T
10 Tablet(s)
1.27
10.60
10 %
Coated tablets: Acidum Mefenamicum 500 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Mephadolor 500 Neo
‐
I
-
T
30 Tablet(s)
3.84
13.40
10 %
Coated tablets: Acidum Mefenamicum 500 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Mephadolor 500 Neo
‐
I
-
T
100 Tablet(s)
11.14
28.55
10 %
Coated tablets: Acidum Mefenamicum 500 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Pregabalin Xiromed 25 mg
14
2.93
12.45
10 %
Capsules: Pregabalinum 25 mg
Xiromed SA
B / SL / SG
FB
G
IP
CI
Pregabalin Xiromed 25 mg
56
8.51
25.75
10 %
Capsules: Pregabalinum 25 mg
Xiromed SA
B / SL / SG
FB
G
IP
Pregabalin Xiromed 50 mg
14
3.37
12.95
10 %
Capsules: Pregabalinum 50 mg
Xiromed SA
B / SL / SG
FB
G
IP
Pregabalin Xiromed 50 mg
84
17.92
36.10
10 %
Capsules: Pregabalinum 50 mg
Xiromed SA
B / SL / SG
FB
G
IP
Pregabalin Xiromed 75 mg
14
3.98
13.60
10 %
Capsules: Pregabalinum 75 mg
Xiromed SA
B / SL / SG
FB
G
IP
Pregabalin Xiromed 75 mg
56
14.99
32.90
10 %
Capsules: Pregabalinum 75 mg
Xiromed SA
B / SL / SG
FB
G
IP
Pregabalin Xiromed 100 mg
84
20.14
38.55
10 %
Capsules: Pregabalinum 100 mg
Xiromed SA
B / SL / SG
FB
G
IP
Pregabalin Xiromed 150 mg
56
20.14
38.55
10 %
Capsules: Pregabalinum 150 mg
Xiromed SA
B / SL / SG
FB
G
IP
Pregabalin Xiromed 150 mg
168
55.37
77.50
10 %
Capsules: Pregabalinum 150 mg
Xiromed SA
B / SL / SG
FB
G
IP
Pregabalin Xiromed 200 mg
84
24.89
43.85
10 %
Capsules: Pregabalinum 200 mg
Xiromed SA
B / SL / SG
FB
G
IP
Pregabalin Xiromed 300 mg
56
24.89
43.85
10 %
Capsules: Pregabalinum 300 mg
Xiromed SA
B / SL / SG
FB
G
IP
Pregabalin Xiromed 300 mg
168
71.97
95.80
10 %
Capsules: Pregabalinum 300 mg
Xiromed SA
B / SL / SG
FB
G
IP
CI
Budesonid Xiromed 3 mg
20
11.08
28.45
10 %
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Xiromed SA
B / SL / SG
FB
G
IP
CI
Budesonid Xiromed 3 mg
50
27.54
46.35
10 %
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Xiromed SA
B / SL / SG
FB
G
IP
CI
Budesonid Xiromed 3 mg
100
53.68
74.80
10 %
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Xiromed SA
B / SL / SG
FB
G
IP
Lasix 20 mg/2 mL
5 ampoule(s)
1.61
11.00
10 %
Injection solution: Furosemidum 20mg / 2ml
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
CI
Salofalk 1000 mg
50 Sachet(s)
45.04
65.40
10 %
Granulate: Mesalazinum 1 g
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 1000 mg
150 Sachet(s)
114.86
141.35
10 %
Granulate: Mesalazinum 1 g
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 3 g
30 Sachet(s)
78.06
101.30
10 %
Granulate: Mesalazinum 3000 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Salofalk 3 g
90
199.05
232.90
10 %
Granulate: Mesalazinum 3000 mg
Dr. Falk Pharma AG
B / SL
FB
G
L
IP
CI
Renvela 2.4 g
60 Sachet(s)
141.67
170.50
10 %
Soluble Powder: Sevelameri Carbonas 2400 mg
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
Rixathon 500 mg/50 ml
1051.32
1159.80
10 %
Concentrate for infusion: Rituximabum 500mg / 50ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Rixathon 100 mg/10 ml
2
421.97
475.35
10 %
Concentrate for infusion: Rituximabum 100mg / 10ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Vegzelma 100 mg/4 ml
257.57
296.55
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Vegzelma 400 mg/16 ml
962.84
1063.55
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
CI
PP
Elvanse 70 mg
30 Capsule(s)
114.64
141.10
10 %
Capsules: Lisdexamfetamini Dimesilas 70 mg
Takeda Pharma AG
A+ / SL
FB
G
L
IP
PP
Herceptin subkutan
600mg/5ml
1484.04
1630.40
10 %
Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Ogivri 150 mg
456.84
513.25
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg
Medius AG
A / SL
FB
G
IP
CI
V/S
Comirnaty®
Original/Omicron BA.1
15/15 µg pro Dosis
gebrauchsfertige
Injektionsdispersion für
Personen ab 18 Jahren
10
PR
PR
k.A.
2 Active Agents
Pfizer AG
B
FB
G
IP
CI
V/S
Comirnaty®
Original/Omicron BA.1
15/15 µg pro Dosis
gebrauchsfertige
Injektionsdispersion für
Personen ab 18 Jahren
195
PR
PR
k.A.
2 Active Agents
Pfizer AG
B
FB
G
IP
CI
Bilaxten 6 mg / ml
5 ml
PR
PR
k.A.
Eye drops: Bilastinum 6 mg/ml
A. Menarini GmbH
B
FB
G
IP
CI
A
Subutex 2 mg
7 Tablet(s)
7.04
16.30
k.A.
Sublingual tablets: Buprenorphinum 2 mg
Indivior Schweiz AG
A+
FB
G
IP
Argatra 100mg/ml
Durchstechflasche(n) à 2.5 ml
PR
PR
k.A.
Concentrate for infusion: Argatrobanum Monohydricum 100 mg/ml
Mitsubishi Tanabe
Pharma GmbH,
Düsseldorf,
Zweigniederlassung
Lenzburg
B
FB
G
IP
Argatra 100mg/ml
6 1 Durchstechflasche(n) à 2.5 ml
PR
PR
k.A.
Concentrate for infusion: Argatrobanum Monohydricum 100 mg/ml
Mitsubishi Tanabe
Pharma GmbH,
Düsseldorf,
Zweigniederlassung
Lenzburg
B
FB
G
IP
Rixathon 500 mg/50 ml
2
PR
PR
k.A.
Concentrate for infusion: Rituximabum 500mg / 50ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Rixathon 100 mg/10 ml
3
PR
PR
k.A.
Concentrate for infusion: Rituximabum 100mg / 10ml
Sandoz
Pharmaceuticals AG
A
FB
G
SIP
IP
CI
Xarelto 15 mg
10 1 Tablet(s)
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B
FB
G
SIP
IP
CI
Xarelto 15 mg
30 x 1
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B
FB
G
SIP
IP
CI
Xarelto 15 mg
100
PR
PR
k.A.
Coated tablets: Rivaroxabanum 15 mg
Bayer (Schweiz) AG
B
FB
G
IP
CI
Dafalgan Grippal
12
PR
PR
k.A.
Granulat zur Herstellung einer Lösung zum Einnehmen: 3 Active Agents
UPSA Switzerland AG
D
FB
G
IP
CI
V/S
Comirnaty
195
PR
PR
k.A.
Konzentrat zur Herstellung einer Injektionsdispersion: Tozinameranum 225 µg
Pfizer AG
B
FB
G
IP
Mylotarg 5 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg
Pfizer AG
A
FB
G
IP
Ceftriaxon Labatec 500 mg
i.v.
10 x 500 mg
PR
PR
k.A.
poudre pour solution injectable: Ceftriaxonum 500 mg
Labatec Pharma SA
A
FB
G
Sevelamer (V03AE02) 5 products
WHO-DDD
DrugBank.ca
L
IP
CI
Renvela
180 Tablet(s)
141.67
169.25
10 %
Coated tablets: Sevelameri Carbonas 800 mg
Sanofi-Aventis
(Suisse) SA
B / SL / SO
FB
G
L
IP
CI
Sevelamercarbonate Salmon
Pharma
180
121.42
148.45
10 %
Coated tablets: Sevelameri Carbonas 800 mg
Salmon Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Renvela 2.4 g
60 Sachet(s)
141.67
170.50
10 %
Soluble Powder: Sevelameri Carbonas 2400 mg
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
CI
Renagel
180 Tablet(s)
150.43
180.00
10 %
Coated tablets: Sevelameri Hydrochloridum 800 mg
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
Renvela 0.8 g
90
PR
PR
k.A.
Soluble Powder: Sevelameri Carbonas 800 mg
Sanofi-Aventis
(Suisse) SA
B
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home